Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(625)
•••
Comment by KayakerBCon Jun 27, 2016 2:23pm
83 Views
Post# 25002043

RE:RE:RE:RE:RE:RE:Update

RE:RE:RE:RE:RE:RE:Update
Also, when one keeps posting about miracle rise in pps even after being blatenly wrong so many times then I have the right to highlight how wrong they have been.

Ya you did that 100 posts ago.  Or was it 200.  We heard you already.

When I started to show how wrong people were then they started to attack me on a personal level.

LOL.  Didn't happen. Dude, you started the personal attacks.  Cry me a river.   Boo hoo.

Go back and read my posts. Why is it OK for people to post this is going to moon with nothing to back it up....

Dude, it just an opinion.  One of many.  Who appointed you Know-It-All board nanny?

As I said before, with predictions from 1.47 to 36, most of us will be wrong.  You having trouble with the math on that?  Guess what?  You'll be wrong too.

but when I say this poster has been wrong on a continous basis then I'm the bad guy! Unbelievable.

You think people here don't realize what forecasts have been wrong?  Doh.   We don't need your help.  Get some freakin' social skills.  

He hasn't been continously wrong, but you've been continuously saying it. 

Yes that and rest of your crappy behaviour makes you the bad guy.

You seem to barely understand what BTI doing or how deals get done.  Do some homwork.  Try making a positive contribution to the board.  Stop harassing people. 

Oh, and thanks for wasting more of my time.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities